CELLBANKER®-GMP: Manufacturing-Grade Cryopreservation
CELLBANKER®-GMP (STEM-CELLBANKER®) is a GMP-grade, chemically defined cryopreservation media. Available in both DMSO-containing and DMSO-free options, it is free from animal-derived ingredients and provides a reliable, high-performance solution for cryopreservation where GMP-grade materials are required. STEM-CELLBANKER™ EX is formulated from FDA-listed inactive ingredients, making it suitable for intravenous administration of cell therapies in a clinical setting.
Key features:
- Chemically defined and animal product free
- FDA Drug Masterfile registered
- Manufactured in compliance with US, EU and PIC/S GMP guidelines
- Maintains pluripotency post thaw
- Enables long term cell storage at -80 C or -196 C
- Direct freeze to -80 C with no rate controlled freezing
| Name | Packsize | Price | Order |
|---|---|---|---|
| Recombinant Human Stem Cell Factor/SCF/c-Kit Ligand Protein | 10 ug | $180.00 | View |
| Recombinant Human Stem Cell Factor/SCF/c-Kit Ligand Protein(C-6His) | 10 ug | $120.00 | View |
| Recombinant Human Stem Cell Factor/SCF/c-Kit Ligand Protein(C-6His) | 50 ug | $340.00 | View |
| Recombinant Mouse Stem Cell Factor/SCF/c-Kit LigandProtein | 50 ug | $525.00 | View |
| Recombinant Rat Stem Cell Factor/SCF Protein(C-6His) | 10 ug | $115.00 | View |
| Recombinant Rat Stem Cell Factor/SCF Protein(C-6His) | 50 ug | $300.00 | View |
Try Before You Buy?
Want to try CELLBANKER-GMP? Try a sample! Validate STEM-CELLBANKER® against your own cells and workflow before committing to a full purchase. Request a complimentary sample and our team will follow up to confirm volume and shipping details.
Cell Viability
Results of cryopreservation analysis performed at the Karolinska Institute on hESC and iPS cells with STEM-CELLBANKER® show significantly higher cell viability over conventional freezing medium while retaining cell pluripotency, normal karyotype and proliferation ability in HS293, HS306 and ChiPSA cell lines (Holm et al., Hum. Reprod. 2010).
Cryopreservation performance test using adipose-derived stromal/stem cells (ADSC) in STEM-CELLBANKER EX
Survival of stem cells after thawing. The growth rates of both HS293 and HS306 frozen with STEM-CELLBANKER® compared with cells frozen with 10% DMSO and FBS.
Custom CELLBANKER®
Custom CELLBANKER® is a cryopreservation solution for scaling your manufacturing process and is available in both GMP grade and research grade depending on your needs. Tailor the formulation, volume, and container type to your needs to ensure seamless incorporation into large-scale cell therapy product manufacturing, with storage to match your workflow and regulatory requirements.
Contact us to discuss your cryopreservation requirements and streamline your strategy with Custom CELLBANKER®.
References and Citations
STEM-CELLBANKER® has been cited in peer-reviewed studies spanning iPSC-derived hepatocytes, mouse embryonic stem cell differentiation, patient-derived medulloblastoma cell lines, amniotic epithelial cells, dental pulp stem cells, and clinical-grade midbrain dopamine progenitors for Parkinson disease therapy.
Recommended: collapse into a ’Show all references’ accordion (default 3–4 visible, expand for full list).
- Holm F, Strom S, Inzunza J, et al. An effective serum- and xeno-free chemically defined freezing procedure for human embryonic and induced pluripotent stem cells. Human Reproduction, Volume 25, Issue 5, May 2010, Pages 1271–1279.
- Inui et al. (2025). Two-dimensionally cultured functional hepatocytes generated from human induced pluripotent stem cell-derived hepatic organoids for pharmaceutical research. Biomaterials. 318:121348.
- Alexander CJ et al. (2019). An Improved Method for Differentiating Mouse Embryonic Stem Cells into Cerebellar Purkinje Neurons. The Cerebellum. 1869: pp 1–16.
- Badodi S et al. (2019). Establishment and Culture of Patient-Derived Primary Medulloblastoma Cell Lines. Methods Mol Biol. 1869:23–36.
- Yamazaki T et al. (2018). Effect of cryopreservation on the appearance and liver function of hepatocyte-like cells in cultures of cirrhotic liver of biliary atresia. In Vitro Cell Dev Biol Anim. Volume 54, Issue 6, pp 401–405.
- Miki T et al. (2016). Biological impact of xeno-free chemically defined cryopreservation medium on amniotic epithelial cells. Stem Cell Research & Therapy. Jan 12;7:8.
- Yamanaka S et al. (2014). A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Scientific Reports 4, Article number: 359.
- Piao J et al. (2021). Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01. Cell Stem Cell. Volume 28, Issue 2, pp 217–229.e7.
- Hata M et al. (2021). Sustainable Effects of Human Dental Pulp Stem Cell Transplantation on Diabetic Polyneuropathy in Streptozotocine-Induced Type 1 Diabetes Model Mice. Cells 2021, 10(9), 2473.
- Bluhmki T et al. (2021). Functional human iPSC-derived alveolar-like cells cultured in a miniaturized 96-Transwell air–liquid interface model. Scientific Reports, 11, Article number: 17028.
- Barber K et al. (2019). Derivation of enteric neuron lineages from human pluripotent stem cells. Nature Protocols. Volume 14, pp 1261–1279.
Real World Application
A study from The Memorial Sloan Kettering Cancer Centre (USA) focused on developing stem cell-derived midbrain dopamine progenitors for the treatment of Parkinson Disease has used STEM-CELLBANKER to store, thaw and then recover these manufactured cells for clinical use in patients.
